More Business Wire
View Older Stories View Newer Stories-
Zai Lab to Announce Third Quarter 2025 Financial Results and Recent Corporate Updates on November 6, 2025
-
AI Infrastructure Partnership (AIP), MGX, and BlackRock’s Global Infrastructure Partners (GIP) to Acquire All Equity in Aligned Data Centers
-
NEUPATH HEALTH TO PRESENT AT THE PLANET MICROCAP SHOWCASE: TORONTO IN PARTNERSHIP WITH THE MICROCAPCLUB ON WEDNESDAY, OCTOBER 22, 2025
-
Amalgamated Bank Announces $25 Million Commitment to Redball Energy, Advancing Rooftop Solar for Underserved Communities
-
Macquarie Asset Management to Lead Sale of Aligned Data Centers at an Enterprise Value of $US40 Billion
-
XCharge North America Launches Oregon's First Solar-Plus-Storage DC Fast-Charging Station in Partnership with Wildhorse Resort & Casino
-
Monro, Inc. to Report Second Quarter Fiscal 2026 Earnings on October 29, 2025
-
Morgan Stanley Reports Third Quarter 2025 Earnings Results
-
Prolink Appoints Vanessa Janus as Chief Workforce Solutions Officer, Driving Strategic Growth and Advancing Healthcare Talent Solutions
-
SkyWater Technology to Announce Third Quarter Financial Results on November 5, 2025
-
IonQ to Report Third Quarter 2025 Financial Results on November 5, 2025
-
Kemper Announces Leadership Transition
-
Advyzon Expands Its All-In-One Platform With Financial Planning, Adding Kevin Hughes to Head Efforts and Tony Leal as a Strategic Advisor
-
Summit Therapeutics to Host ESMO Data Update & Third Quarter Earnings Call on October 20, 2025
-
Arcos Dorados Holdings Inc. Third Quarter 2025 Results Webcast Date and Time
-
ViiV Healthcare’s CLARITY study shows long-acting cabotegravir more acceptable than lenacapavir injections after a single dose, with 90% preferring cabotegravir
-
BTG Pactual Timberland Investment Group Announces 575-Acre Conservation Sale to Appalachia Ohio Alliance
-
Outpost24 Strengthens Global Brand Leadership with Appointment of Liz Drysdale as Chief Marketing Officer
-
FinTech Unicorn Kikoff Names Philippe Clavel as Chief Technology Officer, Expanding its Leadership Bench for the AI Era
-
Alentis Appoints Mark Pruzanski as CEO
-
Augurex Announces Expansion of Availability of the JOINTstat® Diagnostic Test for Rheumatoid Arthritis with MitogenDx
-
Orthofix to Participate in Upcoming Investor Conferences
-
Josh Krichefski Joins PMG as EMEA President
-
Better-for-You Food Suppliers – 34 in all – Join the Queue for Data Sharing with the ReposiTrak Traceability Network
-
Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs
-
Hyperscience Unveils Winter 2025 Release, Advancing Agentic Document Automation for the Enterprise
-
BlackSky to Host Third Quarter 2025 Results Conference Call
-
MindWalk Appoints Dr. Thomas W. Lynch as Chief Business Officer to Accelerate Commercial Expansion
-
Ziff Davis to Participate in One Investor Conference in November
-
88% of Financial Services Leaders Say a Cyber-attack Would Trigger Investor Withdrawals, Omega Systems Report Finds
-
OncoNano Medicine Announces Presentation at AACR-NIC-EORTC International Conference on Molecular Targets and Cancer Therapeutics
-
Iron Mountain Schedules Third Quarter 2025 Earnings Release and Conference Call
-
Pelage Pharmaceuticals Announces $120 Million Series B Financing to Advance Regenerative Medicine Treatments for Hair Loss
-
Phocas Software receives strategic investment from Accel-KKR to fuel middle-market BI and FP&A innovation and growth
-
Novocure to Present New Research for Tumor Treating Fields (TTFields) Therapy at European Association of Neuro-Oncology (EANO) Meeting and the European Society for Medical Oncology (ESMO) Congress
-
Aeva Announces Date for Third Quarter 2025 Results and Conference Call
-
United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025
-
Entegris Declares Quarterly Cash Dividend
-
pOpshelf Welcomes Fresh Brands and Fan Favorites This Fall
-
Merck Announces New Data from Phase 3 Trials Evaluating the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) in Adults with Virologically Suppressed HIV-1 Infecti
-
NRC Health Honors 2025 Leaders in Patient Experience and Loyalty
-
NGL Energy Partners Announces Earnings Call
-
Dollar Tree to Outline Operational and Financial Outlook at 2025 Investor Day
-
CHAOS Industries and Forterra Announce Partnership to Deliver Integrated Autonomous Counter‑UAS Capabilities
-
ITT’s KONI Recognized as 2025 Railsponsible Supplier Award Winner for Sustainable Product Lifecycle Extension
-
Citizens Financial Group, Inc. Reports Third Quarter 2025 Net Income of $494 million and EPS of $1.05
-
Sable Offshore Corp. Statement on California Coastal Commission Litigation
-
Micro Interventional Devices Receives FDA Approval of the STTAR-US IDE Pivotal Trial for its MIA™-T Percutaneous Tricuspid Annuloplasty System
-
Next Health Launches World-Class Scientific Advisory Council to Revolutionize Longevity Medicine and Proactive Healthcare
-
Bunge Announces Reporting Segment Changes and Recast Outlook
